Edwards Lifesciences Corp

NYSE: EW
$88.61
+$0.86 (+1.0%)
Closing price April 24, 2024
Edwards Lifesciences Corp specializes in innovative solutions for heart disease and critical care monitoring worldwide. It's known for its Edwards SAPIEN family of valves, offering minimally invasive aortic valve replacements. The company also tackles mitral and tricuspid valve diseases with its PASCAL PRECISION and Cardioband systems. Beyond valve solutions, Edwards provides surgical and critical care products like the INSPIRIS RESILLA aortic valve and advanced hemodynamic monitoring systems. Founded in 1958 and based in Irvine, California, Edwards Lifesciences is a pioneer in improving patient outcomes in heart care and intensive care units.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Adobe, Bank of America, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX Companies and Valero Energy.
While these companies are better suited for accounts that have a higher risk tolerance, they all make good sense now, and all have outstanding upside potential.
While these four stocks are better suited for accounts that have a higher risk tolerance, they all make good sense now and all have outstanding upside potential.
These 10 stocks received multiple analyst rating upgrades or price target hikes and also managed to have a gain for the week, even during the sell-off.
The top analyst upgrades, downgrades and other research calls from Friday include Alibaba, Alphabet, Amazon, Amgen, Apple, Mastercard, Nokia, Shopify and US Steel.
These five companies not only match up with the top Jefferies themes for this year, but they hit all the required metrics to be top picks for 2018.
The top analyst upgrades, downgrades and other research calls from Thursday include Alphabet, Avon, Bank of America, Intel, Roku, Snap and Western Digital.
These three red-hot companies continue to dominate their specific spheres of the medical technology world, and their stocks have had outstanding runs.
With the passage of tax reform looking almost certain, and with companies continuing to prove that all-time highs in the market will not hurt spending cash on share buybacks, the continuation of...
A new Jefferies research report focuses on the frm's new top growth picks, and we found four that may not only be great trades for the balance of 2017, but good stocks to own as we head into the new...
Despite the concerns over the struggles of politicians to craft a new health care plan for the United States, the health care sector, and many of its subsectors, have had an outstanding first half to...
Not only do these top growth companies look poised for additional gains, they may have even more of a tailwind if the economy starts to pick up.
Overall the market had a relatively flat day, after posting two days of incredible gains. In the past few days broad markets peaked again and hit new all-time highs. Major bank stocks were driving...
The top analyst upgrades, downgrades and initiations seen on Monday include Best Buy, Groupon, Snap, Starbucks, Weatherford, Alphabet, CIT, Match and Wix.com.
While the volume of insider trading has slowed due to fourth-quarter earnings being reported, we continued to see some big sales in technology.